FRYL was first identified as a novel fusion partner of the mixed lineage leukemia (MLL) gene that was reported in patients who developed treatment-related acute lymphoblastic leukemia (ALL) (Hayette et al., 2005; Sait et al., 2007). The gene discussed is FRYL; the disease is acute lymphoblastic leukemia.